| Literature DB >> 29577412 |
Masataka Oda1,2, Mie Kurosawa1, Hirofumi Yamamoto3, Hisanori Domon1, Tatsuya Kimura1, Toshihito Isono1, Tomoki Maekawa4, Naoki Hayashi2, Noriteru Yamada2, Yui Furue2, Daichi Kai2, Yutaka Terao1.
Abstract
Vizantin is an insoluble adjuvant that activates macrophages and lymphocytes. Recently, 2,2',3,3',4,4'-hexasulfated-vizantin (sulfated vizantin), which enables solubilization of vizantin, was developed by the present team. Sulfated vizantin was found to enhance bactericidal activity against multi-drug resistant Pseudomonas aeruginosa in RAW264.7 cells. In addition, spread of P. aeruginosa was inhibited in RAW264.7 cells treated with sulfated vizantin. When only sulfated vizantin and P. aeruginosa were incubated, sulfated vizantin did not affect growth of P. aeruginosa. Formation of DNA-based extracellular traps (ETs), a novel defense mechanism in several types of innate immune cells, helps to eliminate pathogens. In the present study, ET-forming macrophages constituted the majority of immune cells. Sulfated vizantin induced ET formation in RAW264.7 cells, whereas a Ca-chelating reagent, EDTA, and T-type calcium channel blocker, tetrandrine, inhibited ET formation and attenuated inhibition of spread of P. aeruginosa in sulfated vizantin-treated cells. Thus, sulfated vizantin induces ET formation in phagocytic cells in a Ca-dependent manner, thus preventing spread of P. aeruginosa. Hence, sulfated vizantin may be useful in the management of infectious diseases.Entities:
Keywords: Pseudomonas aeruginosa; extracellular trap; macrophage; sulfated vizantin
Mesh:
Substances:
Year: 2018 PMID: 29577412 DOI: 10.1111/1348-0421.12589
Source DB: PubMed Journal: Microbiol Immunol ISSN: 0385-5600 Impact factor: 1.955